Ulla Axdorph

873 total citations
21 papers, 652 citations indexed

About

Ulla Axdorph is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ulla Axdorph has authored 21 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ulla Axdorph's work include Lymphoma Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Ulla Axdorph is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Ulla Axdorph collaborates with scholars based in Sweden, United States and Czechia. Ulla Axdorph's co-authors include Magnus Björkholm, Gunnar Grimfors, Anna Porwit‐MacDonald, Ola Landgren, Ann Langius‐Eklöf, Lena Wettergren, Jan Sjöberg, C. Wedelin, A. Bowling and Erik Svedmyr and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and British Journal of Haematology.

In The Last Decade

Ulla Axdorph

21 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulla Axdorph Sweden 14 334 271 140 89 84 21 652
S W Crawford United States 13 163 0.5× 150 0.6× 144 1.0× 56 0.6× 125 1.5× 19 681
Gianluigi Cetto Italy 16 173 0.5× 291 1.1× 204 1.5× 53 0.6× 88 1.0× 43 675
Miriam Tao Singapore 16 477 1.4× 479 1.8× 108 0.8× 135 1.5× 123 1.5× 58 941
Roberta Babare Italy 8 142 0.4× 192 0.7× 120 0.9× 56 0.6× 44 0.5× 13 597
Irène Biasoli Brazil 19 712 2.1× 626 2.3× 170 1.2× 171 1.9× 180 2.1× 44 1.2k
Jeffrey Davis Canada 17 114 0.3× 152 0.6× 323 2.3× 146 1.6× 78 0.9× 41 1.0k
Sheila Breslin United States 10 391 1.2× 264 1.0× 225 1.6× 161 1.8× 136 1.6× 13 689
A.M. Hernández Spain 14 408 1.2× 322 1.2× 84 0.6× 205 2.3× 65 0.8× 77 1.1k
Chitose Ogawa Japan 13 98 0.3× 170 0.6× 135 1.0× 79 0.9× 87 1.0× 79 674
Heidi Glosli Norway 16 166 0.5× 194 0.7× 326 2.3× 28 0.3× 50 0.6× 42 724

Countries citing papers authored by Ulla Axdorph

Since Specialization
Citations

This map shows the geographic impact of Ulla Axdorph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulla Axdorph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulla Axdorph more than expected).

Fields of papers citing papers by Ulla Axdorph

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulla Axdorph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulla Axdorph. The network helps show where Ulla Axdorph may publish in the future.

Co-authorship network of co-authors of Ulla Axdorph

This figure shows the co-authorship network connecting the top 25 collaborators of Ulla Axdorph. A scholar is included among the top collaborators of Ulla Axdorph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulla Axdorph. Ulla Axdorph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cherif, Honar, Ulla Axdorph, Mats Kalin, & Magnus Björkholm. (2012). Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection. Scandinavian Journal of Infectious Diseases. 45(2). 112–116. 23 indexed citations
2.
Norda, Rut, et al.. (2008). Recognition of Intercenter Differences May Help Develop Best Practice. Therapeutic Apheresis and Dialysis. 12(5). 347–354. 9 indexed citations
3.
Landgren, Ola, Ulla Axdorph, Thomas R. Fears, et al.. (2006). A population-based cohort study on early-stage Hodgkin lymphoma treated with radiotherapy alone: with special reference to older patients. Annals of Oncology. 17(8). 1290–1295. 11 indexed citations
4.
Landgren, Ola, Magnus Björkholm, Helle Bossen Konradsen, et al.. (2004). A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma. Journal of Internal Medicine. 255(6). 664–673. 39 indexed citations
5.
Landgren, Ola, Edneia Tani, Magdalena Czader, et al.. (2004). A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomas. The Hematology Journal. 5(1). 69–76. 72 indexed citations
6.
Wettergren, Lena, Magnus Björkholm, Ulla Axdorph, & Ann Langius‐Eklöf. (2004). Determinants of Health-Related Quality of Life in Long-Term Survivors of Hodgkin's Lymphoma. Quality of Life Research. 13(8). 1369–1379. 78 indexed citations
7.
Wikman, Agneta, et al.. (2004). Characterization of red cell autoantibodies in consecutive DAT-positive patients with relation to in vivo haemolysis. Annals of Hematology. 84(3). 150–158. 30 indexed citations
8.
Wettergren, Lena, Magnus Björkholm, Ulla Axdorph, A. Bowling, & Ann Langius‐Eklöf. (2003). Individual quality of life in long-term survivors of Hodgkin's lymphoma – a comparative study. Quality of Life Research. 12(5). 545–554. 54 indexed citations
9.
Carde, Patrice, Serge Koscielny, Jeremy Franklin, et al.. (2002). Early response to chemotherapy: a surrogate for final outcome of Hodgkin's disease patients that should influence initial treatment length and intensity?. Annals of Oncology. 13. 86–91. 43 indexed citations
10.
Axdorph, Ulla, Anna Porwit‐MacDonald, Jan Sjöberg, Gunnar Grimfors, & Magnus Björkholm. (2002). T‐cell‐rich B‐cell lymphoma – diagnostic and therapeutic aspects. Apmis. 110(5). 379–390. 12 indexed citations
11.
Axdorph, Ulla, Leif Stenke, Gunnar Grimfors, et al.. (2002). Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase – a report from the Swedish CML Group. British Journal of Haematology. 118(4). 1048–1054. 16 indexed citations
12.
Landgren, Ola, Johan Askling, Paul W. Dickman, et al.. (2002). Parental longevity and survival in elderly patients with Hodgkin's lymphoma.. PubMed. 87(6). 596–601. 6 indexed citations
13.
Axdorph, Ulla, Anna Porwit‐MacDonald, Gunnar Grimfors, & Magnus Björkholm. (2001). Tissue Eosinophilia in Relation to Immunopathological and Clinical Characteristics in Hodgkin's Disease. Leukemia & lymphoma. 42(5). 1055–1065. 30 indexed citations
14.
Landgren, Ola, Ulla Axdorph, Hans Jacobsson, et al.. (2000). Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease. Medical Oncology. 17(3). 174–178. 3 indexed citations
15.
Axdorph, Ulla, Jan Sjöberg, Gunnar Grimfors, et al.. (2000). Biological markers may add to prediction of outcome achieved by the international prognostic score in Hodgkin's disease. Annals of Oncology. 11(11). 1405–1411. 41 indexed citations
16.
Sjöberg, Jan, et al.. (1999). Tumour necrosis factor‐α cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia. British Journal of Haematology. 104(2). 346–349. 31 indexed citations
17.
Axdorph, Ulla, Anna Porwit‐MacDonald, Jan Sjöberg, et al.. (1999). Epstein–Barr virus expression in Hodgkin’s disease in relation to patient characteristics, serum factors and blood lymphocyte function. British Journal of Cancer. 81(7). 1182–1187. 40 indexed citations
18.
Björkholm, Magnus, Ulla Axdorph, Gunnar Grimfors, et al.. (1995). Fixed versus response-adapted MOPP/ABVD chemotherapy in Hodgkin's disease. Annals of Oncology. 6(9). 895–899. 28 indexed citations
19.
Axdorph, Ulla, et al.. (1995). Leucocyte doubling time is a useful predictor of progression‐free survival in chronic lymphocytic leukaemia. Journal of Internal Medicine. 237(2). 205–209. 2 indexed citations
20.
Axdorph, Ulla, Göran Laurell, & Magnus Björkholm. (1993). Monitoring of hearing during treatment of leukaemia with special reference to the use of amikacin. Journal of Internal Medicine. 233(5). 401–407. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S W Crawford Breakdown of academic impact, for papers by Gianluigi Cetto Breakdown of academic impact, for papers by Miriam Tao Breakdown of academic impact, for papers by Roberta Babare Breakdown of academic impact, for papers by Irène Biasoli Breakdown of academic impact, for papers by Jeffrey Davis Breakdown of academic impact, for papers by Sheila Breslin Breakdown of academic impact, for papers by A.M. Hernández Breakdown of academic impact, for papers by Chitose Ogawa Breakdown of academic impact, for papers by Heidi Glosli
Rankless by CCL
2026